<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00746135</url>
  </required_header>
  <id_info>
    <org_study_id>H37</org_study_id>
    <nct_id>NCT00746135</nct_id>
  </id_info>
  <brief_title>TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study</brief_title>
  <acronym>TRI-V</acronym>
  <official_title>TRI-V Resynchronization in Paced Heart Failure Patients With ICD Indication.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It's the aim of this study to investigate the impact of Right Ventricular (RV) lead position
      (RV-apex, His bundle area, RV-apex+His bundle area) in combination with individually
      optimized Left Ventricular (LV) lead placement and CRT timing on the outcome of cardiac
      resynchronization therapy (CRT).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement according to Packer's &quot;Heart Failure Clinical Composite Respond&quot;</measure>
    <time_frame>12 months post implant</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative Increase in Left Ventricular dp/dt</measure>
    <time_frame>At Implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiopulmonary Capacity(Spiroergometry)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in B-type natriuretic Peptide (BNP)-Concentration</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 min walk test</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QoL assessment(&quot;Minnesota Living with Heart Failure = MLHF)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12 channel ECG</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2D-echo optimized EF</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications and morbidity</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional Biventricular Stimulation: RV Apex and LV Lead Tip</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anodal-Cathodal Biventricular Stimulation: cathodal LV Stimulation und anodal RVHis Stimulation = &quot;Anodal-cathodal Bi-V&quot;.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anodal-Cathodal Tri-V Stimulation: RV-apex and LV and RV-His</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Device Implantation</intervention_name>
    <description>RV apical pacing lead, RV pacing lead at HIS bundle position, LV pacing lead implantation</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
    <arm_group_label>C</arm_group_label>
    <other_name>CRT-D Devices:</other_name>
    <other_name>Atlas™ II+ HF / V-367 /St. Jude Medical</other_name>
    <other_name>Epic™ II+ HF / V-357 / St. Jude Medical</other_name>
    <other_name>Promote™ / 3207-36 / 3213-36 / St. Jude Medical</other_name>
    <other_name>Adapters:</other_name>
    <other_name>VIS 16 / Dr. Osypka GmbH</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with indication for CRT-D: NYHA III-IV congestive heart failure, in spite of
             optimal medical treatment for their congestive heart failure

          -  LVEDD &gt; 55 mm or &gt; 30 mm/m² BSA

          -  EF &lt; 35%

          -  Sinus rhythm and one of the following criteria:

          -  QRS &gt;= 120 ms and PQ &gt;= 200ms

          -  or

          -  2nd / 3rd degree AV block

          -  Written informed consent

        Exclusion Criteria:

          -  pacemaker indication (without ICD indication)

          -  tricuspidal valve and/or aortic valve replacement

          -  Indication for revascularization.

          -  less than 3 month after heart surgery or myocardial infarction

          -  hypertrophic obstructive cardiomyopathy

          -  intravenous catecholamine treatment

          -  uncorrected thyroid function

          -  severe kidney disorder (creatinin &gt;2,5mg%)

          -  no written patient consent

          -  insufficient patient compliance

          -  participating in another study

          -  life expectancy &lt; 1 year due to other severe disease

          -  age &lt; 18 years

          -  no contraception (young women) or pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolfgang Kranig, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Departement of Cardiology - Electrophysiology- Heart Centre Osnabrück - Bad Rothenfelde</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Departement of Cardiology - Electrophysiology- Heart Centre Osnabrück - Bad Rothenfelde</name>
      <address>
        <city>Bad Rothenfelde</city>
        <zip>49214</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2008</study_first_submitted>
  <study_first_submitted_qc>September 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2008</study_first_posted>
  <last_update_submitted>October 21, 2016</last_update_submitted>
  <last_update_submitted_qc>October 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart failure (NYHA class III and IV)</keyword>
  <keyword>Ventricular Dyssynchrony</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

